Catalyst Wire Dossier Catalyst Wire Dossier

Idiotype vaccine (tumor-derived immunoglobulin idiotype)

tumor-derived immunoglobulin idiotype vaccine · National Cancer Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Idiotype vaccine (tumor-derived immunoglobulin idiotype), covering 2017-07-02 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype [Phase 1]

See pricing